Skip to main content
Premium Trial:

Request an Annual Quote

Cellomics, GE Healthcare to Co-Develop Cellular Imaging Informatics Platform

NEW YORK, June 29 (GenomeWeb News) - Cellomics and GE Healthcare will co-develop an informatics platform for analyzing data from GE Healthcare's cellular imaging systems, the companies said today.


The firms will collaborate to develop and market a software interface that will integrate data and images from GE Healthcare's IN Cell Analyzer 3000 and IN Cell Analyzer 1000 sub-cellular imaging systems with Cellomics' Cellomics Store and vHCS Discovery ToolBox informatics tools.


Last week, Cellomics said that GE Healthcare -- formed by the merger of Amersham Biosciences and GE Medical Systems in April -- had licensed its portfolio of high-content screening patents in a non-exclusive agreement.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.